Inhibition of NADPH oxidase mediates protective effect of cardiotonic pills against rat heart ischemia/reperfusion injury

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Yang, Xiao Yuan ^a   Zhao, Na ^a   Liu, Yu Ying ^a   Hu, Bai He ^a   Sun, Kai ^a   Chang, Xin ^a   Wei, Xiao Hong ^a   Fan, Jing Yu ^a   Han, Jing Yan ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b State Administration of Traditional Chinese Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTONIC AGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOSOL; HEART MUSCLE BLOOD FLOW; HEART MUSCLE INJURY; HEART PROTECTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MICROANGIOPATHY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY;

EID: 84880170310     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/728020     Document Type: Article

References (53)

1. American Heart Association, Learn and Live. Know the Facts, Get the Stats 2006 Dallas, Tex, USA American Heart Association
2. Powers S. K., Murlasits Z., Wu M., Kavazis A. N., Ischemia-reperfusion- induced cardiac injury: a brief review. Medicine and Science in Sports and Exercise 2007 39 9 1529 1536 2-s2.0-34548437520 10.1249/mss.0b013e3180d099c1
3. Ambrosio G., Becker L. C., Hutchins G. M., Weisman H. F., Weisfeldt M. L., Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury. Circulation 1986 74 6 1424 1433 2-s2.0-0022982366
4. Hamilton K. L., Antioxidants and cardioprotection. Medicine and Science in Sports and Exercise 2007 39 9 1544 1553 2-s2.0-34548463341 10.1249/mss.0b013e3180d099e8
5. Pagliaro P., Moro F., Tullio F., Perrelli M., Penna C., Cardioprotective pathways during reperfusion: focus on redox signaling and other modalities of cell signaling. Antioxidants and Redox Signaling 2011 14 5 833 850 2-s2.0-79551656099 10.1089/ars.2010.3245
6. Webster K. A., Mitochondrial membrane permeabilization and cell death during myocardial infarction: roles of calcium and reactive oxygen species. Future Cardiology 2012 8 6 863 884 10.2217/fca.12.58
7. Xiao L., Pimentel D. R., Wang J., Singh K., Colucci W. S., Sawyer D. B., Role of reactive oxygen species and NAD(P)H oxidase in α 1-adrenoceptor signaling in adult rat cardiac myocytes. The American Journal of Physiology 2002 282 4 C926 C934 2-s2.0-0036083322
8. Griendling K. K., Minieri C. A., Ollerenshaw J. D., Alexander R. W., Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circulation Research 1994 74 6 1141 1148 2-s2.0-0028365310
9. Görlach A., Brandes R. P., Nguyen K., Amidi M., Dehghani F., Busse R., A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circulation Research 2000 87 1 26 32 2-s2.0-0034617071
10. Johar S., Cave A. C., Narayanapanicker A., Grieve D. J., Shah A. M., Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. FASEB Journal 2006 20 9 1546 1548 2-s2.0-33845603497 10.1096/fj.05-4642fje
11. Bedard K., Krause K. H., The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological Reviews 2007 87 1 245 313 2-s2.0-33846794822 10.1152/physrev.00044.2005
12. Fukui T., Yoshiyama M., Hanatani A., Omura T., Yoshikawa J., Abe Y., Expression of p22-phox and gp91-phox, essential components of NADPH oxidase, increases after myocardial infarction. Biochemical and Biophysical Research Communications 2001 281 5 1200 1206 2-s2.0-0034805555 10.1006/bbrc.2001.4493
13. Krijnen P. A. J., Meischl C., Hack C. E., Meijer C. J. L. M., Visser C. A., Roos D., Niessen H. W. M., Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction. Journal of Clinical Pathology 2003 56 3 194 199 2-s2.0-0037340087 10.1136/jcp.56.3.194
14. Loukogeorgakis S. P., van den Berg M. J., Sofat R., Nitsch D., Charakida M., Haiyee B., de Groot E., MacAllister R. J., Kuijpers T. W., Deanfield J. E., Role of NADPH oxidase in endothelial ischemia/reperfusion injury in humans. Circulation 2010 121 21 2310 2316 2-s2.0-77953229365 10.1161/CIRCULATIONAHA.108. 814731
15. Looi Y. H., Grieve D. J., Siva A., Walker S. J., Anilkumar N., Cave A. C., Marber M., Monaghan M. J., Shah A. M., Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction. Hypertension 2008 51 2 319 325 2-s2.0-38549128215 10.1161/HYPERTENSIONAHA.107.101980
16. Qin F., Simeone M., Patel R., Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction. Free Radical Biology and Medicine 2007 43 2 271 281 2-s2.0-34250876364 10.1016/j.freeradbiomed.2007.04.021
17. Zhao N., Liu Y., Wang F., Hu B., Sun K., Chang X., Pan C., Fan J., Wei X., Li X., Wang C., Guo Z., Han J., Cardiotonic pills, a compound Chinese medicine, protects ischemia-reperfusion-induced microcirculatory disturbance and myocardial damage in rats. The American Journal of Physiology 2010 298 4 H1166 H1176 2-s2.0-77949739128 10.1152/ajpheart.01186.2009
18. Wei X. H., Liu Y. Y., Li Q., Yan L., Hu B. H., Pan C. S., Li Z. X., Chang X., Fan J. Y., Zhao N., Sun K., Huang P., Wang C. S., Fan T. P., Han J. Y., Treatment with cardiotonic pills after ischemia-reperfusion ameliorates myocardial fibrosis in rats. Microcirculation 2013 20 1 17 29 10.1111/micc.12002
19. Qiao Z., Ma J., Liu H., Evaluation of the antioxidant potential of Salvia miltiorrhiza ethanol extract in a rat model of ischemia-reperfusion injury. Molecules 2011 16 12 10002 10012 2-s2.0-84555188090 10.3390/molecules161210002
20. Han J., Horie Y., Fan J., Sun K., Guo J., Miura S., Hibi T., Potential of 3,4-dihydroxy-phenyl lactic acid for ameliorating ischemia-reperfusion-induced microvascular disturbance in rat mesentery. The American Journal of Physiology 2009 296 1 G36 G44 2-s2.0-58249117785 10.1152/ajpgi.90284.2008
21. Zhao G., Zhang H., Ye T., Xiang Z., Yuan Y., Guo Z., Zhao L., Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B. Food and Chemical Toxicology 2008 46 1 73 81 2-s2.0-36848999824 10.1016/j.fct.2007.06.034
22. Son H. Y., Han H. S., Jung H. W., Park Y., Panax notoginseng attenuates the infarct volume in rat ischemic brain and the inflammatory response of microglia. Journal of Pharmacological Sciences 2009 109 3 368 379 2-s2.0-67249152098 10.1254/jphs.08197FP
23. Fan H., Yang L., Fu F., Cardioprotective effects of salvianolic acid a on myocardial ischemia-reperfusion injury in vivo and in vitro. Evidence-Based Complementary and Alternative Medicine 2012 2012 9 508938 10.1155/2012/508938
24. Liu Y., Yang J., Sun K., Wang C., Han J., Liao F., Determination of erythrocyte flow velocity by dynamic grey scale measurement using off-line image analysis. Clinical Hemorheology and Microcirculation 2009 43 3 265 267 2-s2.0-70350451932 10.3233/CH-2009-1238
25. Vinten-Johansen J., Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovascular Research 2004 61 3 481 497 2-s2.0-1142309740 10.1016/j.cardiores.2003.10.011
26. Zhou H., Liao J., Aloor J., Nie H., Wilson B. C., Fessler M. B., Gao H. M., Hong J. S., CD11b/CD18 (Mac-1) is a novel surface receptor for extracellular double-stranded RNA to mediate cellular inflammatory responses. Journal of Immunology 2013 190 1 115 125 10.4049/jimmunol.1202136
27. Entman M. L., Smith C. W., Postreperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovascular Research 1994 28 9 1301 1311 2-s2.0-0027937463
28. Frangogiannis N. G., Smith C. W., Entman M. L., The inflammatory response in myocardial infarction. Cardiovascular Research 2002 53 1 31 47 2-s2.0-0036136667 10.1016/S0008-6363(01)00434-5
29. Rahman A., Kefer J., Bando M., Niles W. D., Malik A. B., E-selectin expression in human endothelial cells by TNF- α -induced oxidant generation and NF- B activation. The American Journal of Physiology 1998 275 3 L533 L544 2-s2.0-0031706281
30. Ji X. Y., Tan B. K., Zhu Y. Z., Salvia miltiorrhiza and ischemic diseases. Acta Pharmacologica Sinica 2000 21 12 1089 1094 2-s2.0-0034534954
31. Han J., Fan J., Horie Y., Miura S., Cui D., Ishii H., Hibi T., Tsuneki H., Kimura I., Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacology and Therapeutics 2008 117 2 280 295 2-s2.0-38349123913 10.1016/j.pharmthera.2007.09.008
32. Kunwar A., Priyadarsini K. I., Free radicals, oxidative stress and importance of antioxidants in human health. Journal of Medical and Allied Sciences 2011 1 2 53 60
33. Mathew B. B., Tiwari A., Jatawa S. K., Free radicals and antioxidants: a review. Journal of Pharmacy Research 2011 4 12 4340 4343
34. Kohen R., Nyska A., Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicologic Pathology 2002 30 6 620 650 2-s2.0-0036867895 10.1080/ 01926230290166724
35. GISSI-Prevenzione Investigators, Dietary supplementation with N-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. The Lancet 1999 354 9177 447 455 2-s2.0-0345109256 10.1016/S0140-6736(99)07072-5
36. McCord J. M., Therapeutic control of free radicals. Drug Discovery Today 2004 9 18 781 782 2-s2.0-4444285887 10.1016/S1359-6446(04)03211-8
37. Day B. J., Catalytic antioxidants: a radical approach to new therapeutics. Drug Discovery Today 2004 9 13 557 566 2-s2.0-2942623947 10.1016/S1359-6446(04)03139-3
38. Lonn E., Bosch J., Yusuf S., Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. The Journal of the American Medical Association 2005 293 11 1338 1347 2-s2.0-20044383911 10.1001/jama.293.11.1338
39. Guzik T. J., Harrison D. G., Vascular NADPH oxidases as drug targets for novel antioxidant strategies. Drug Discovery Today 2006 11 11-12 524 533 2-s2.0-33646525680 10.1016/j.drudis.2006.04.003
40. McNally J. S., Davis M. E., Giddens D. P., Saha A., Hwang J., Dikalov S., Jo H., Harrison D. G., Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. The American Journal of Physiology 2003 285 6 H2290 H2297 2-s2.0-0344185339
41. Landmesser U., Dikalov S., Price S. R., McCann L., Fukai T., Holland S. M., Mitch W. E., Harrison D. G., Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. Journal of Clinical Investigation 2003 111 8 1201 1209 2-s2.0-0037399439 10.1172/JCI200314172
42. Kim K., Takeda K., Sethi R., Pracyk J. B., Tanaka K., Zhou Y. F., Yu Z., Ferrans V. J., Bruder J. T., Kovesdi I., Irani K., Goldschmidt-Clermont P., Finkel T., Protection from reoxygenation injury by inhibition of rac1. Journal of Clinical Investigation 1998 101 9 1821 1826 2-s2.0-0032080913
43. Frantz S., Brandes R. P., Hu K., Rammelt K., Wolf J., Scheuermann H., Ertl G., Bauersachs J., Left ventricular remodeling after myocardial infarction in mice with targeted deletion of the NADPH oxidase subunit gp91PHOX. Basic Research in Cardiology 2006 101 2 127 132 2-s2.0-32844454895 10.1007/s00395-005-0568-x
44. Hoffmeyer M. R., Jones S. P., Ross C. R., Sharp B., Grisham M. B., Laroux F. S., Stalker T. J., Scalia R., Lefer D. J., Myocardial ischemia/reperfusion injury in NADPH oxidase-deficient mice. Circulation Research 2000 87 9 812 817 2-s2.0-0034721810
45. Ikeda Y., Young L. H., Scalia R., Ross C. R., Lefer A. M., PR-39, a proline/arginine-rich antimicrobial peptide, exerts cardioprotective effects in myocardial ischemia-reperfusion. Cardiovascular Research 2001 49 1 69 77 2-s2.0-0034749320 10.1016/S0008-6363(00)00226-1
46. - and systolic blood pressure in mice. Circulation Research 2001 89 5 408 414 2-s2.0-0035980160
47. Diatchuk V., Lotan O., Koshkin V., Wikstroem P., Pick E., Inhibition of NADPH oxidase activation by 4-(2-aminoethyl)-benzenesulfonyl fluoride and related compounds. The Journal of Biological Chemistry 1997 272 20 13292 13301 2-s2.0-0030915096 10.1074/jbc.272.20.13292
48. Stolk J., Hiltermann T. J., Dijkman J. H., Verhoeven A. J., Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. The American Journal of Respiratory Cell and Molecular Biology 1994 11 1 95 102 2-s2.0-0028473441
49. Tsai M., Lin Y., Huang Y., Effects of salvianolic acids on oxidative stress and hepatic fibrosis in rats. Toxicology and Applied Pharmacology 2010 242 2 155 164 2-s2.0-71049180223 10.1016/j.taap.2009.10.002
50. Gao S., Liu Z., Li H., Little P. J., Liu P., Xu S., Cardiovascular actions and therapeutic potential of tanshinone IIA. Atherosclerosis 2012 220 1 3 10 2-s2.0-84155164808 10.1016/j.atherosclerosis.2011.06.041
51. Karthik D., Viswanathan P., Anuradha C. V., Administration of rosmarinic acid reduces cardiopathology and blood pressure through inhibition of p22phox NADPH oxidase in fructose-fed hypertensive rats. Journal of Cardiovascular Pharmacology 2011 58 5 514 521 2-s2.0-80955135026 10.1097/FJC.0b013e31822c265d
52. Holland J. A., O'Donnell R. W., Chang M., Johnson D. K., Ziegler L. M., Endothelial cell oxidant production: effect of NADPH oxidase inhibitors. Endothelium 1999 7 2 109 119 2-s2.0-0033509231
53. Xie X., Liu H., Yang M., Zuo C., Deng Y., Fan J., Ginsenoside Rb1, a panoxadiol saponin against oxidative damage and renal interstitial fibrosis in rats with unilateral ureteral obstruction. Chinese Journal of Integrative Medicine 2009 15 2 133 140 2-s2.0-65349164609 10.1007/s11655-009-0133-9